Oyakawa, Takuya
Iida, Kei
Kusuhara, Masatoshi
Kenmotsu, Hirotsugu
Sugino, Takashi
Article History
Received: 24 May 2017
Accepted: 20 June 2017
First Online: 28 June 2017
Compliance with ethical standards
:
: Takuya Oyakawa reports personal fees from Bristol-Myers Squibb, personal fees from Sumitomo Dainippon Pharma, personal fees from Pfizer. Kei Iida reports personal fees from Ono Pharmaceutical Co, Ltd., personal fees from Bristol-Myers, personal fees from Daiichi Sankyo, personal fees from Toa eiyo Ltd. Hirotsugu Kenmotsu reports grants and personal fees from AstraZeneca K.K., grants and personal fees from Chugai Pharmaceutical Co, Ltd., personal fees from Ono Pharmaceutical Co, Ltd., personal fees from Bristol-Myers K.K, grants and personal fees from Boeringer Ingelheim, personal fees from Eli Lilly K.K, personal fees from Kyowa Hakko Kirin Co., Ltd. Masatoshi Kusuhara has nothing to disclose. Takashi Sugino has nothing to disclose.
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.